Fluge & Mella's pre-trial study highlights life-changing potential of rituximab
Sasha gives the background and Simon gives the interpretation of the latest study from Haukeland, published today...
Discuss the article on the Forums.

Mikovits interview states the FDA will confirm WPI findings in a Sept publication

Discussion in 'Media, Interviews, Blogs, Talks, Events about XMRV' started by Stone, Aug 16, 2010.

  1. Dr. Yes

    Dr. Yes Shame on You

    Messages:
    867
    Likes:
    22
    Apparently a lot has happened since 1992...

    Yeah, recombination/pseudotyping can screw up cladistic analyses of retroviruses in particular. Not only XMRV but just about all MLVs seem quite capable of swapping DNA, so the entire "MLV-related virus" population could make for a very weird-looking family tree if the implications of the recent NCI/ WPI work and the Alter study are any indication. It will at least help to have complete viral genomes; just looking at sections of the gag gene won't be enough.
     

See more popular forum discussions.

Share This Page